Patents by Inventor Patricia Ouadji

Patricia Ouadji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bilayer composition for the sustained release of acetaminophen and tramadol
    Patent number: 8895066
    Abstract: The invention relates to a bilayer composition for the delivery of acetaminophen and tramadol over at least a twelve hour period following initial administration. A single administration of the bilayer composition can provide analgesia starting in less than half an hour to about one hour after initial administration with a duration of at least twelve hours after initial administration.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: November 25, 2014
    Assignees: Paladin Labs Inc., Paladin Labs Europe Limited, Paladin Labs (Barbados) Inc.
    Inventors: Ali Bichara, Sonia Gervais, Dorothee Le Garrec, Patricia Ouadji, Vinayak Sant, Shiva Gosein, Vincent Lemaire, Samir Taga, Damon Smith
  • Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
    Publication number: 20090130183
    Abstract: The invention relates to a bilayer composition for the delivery of acetaminophen and tramadol over at least a twelve hour period following initial administration. A single administration of the bilayer composition can provide analgesia starting in less than half an hour to about one hour after initial administration with a duration of at least twelve hours after initial administration.
    Type: Application
    Filed: October 15, 2008
    Publication date: May 21, 2009
    Inventors: Ali Bichara, Sonia Gervais, Dorothee Le Garrec, Patricia Ouadji, Vinayak Sant, Shiva Gosein, Vincent Lemaire, Samir Taga, Damon Smith
  • Sustained-release tramadol formulations with 24-hour efficacy
    Publication number: 20070003618
    Abstract: A sustained-release tramadol formulation oral administration is provided which, upon initial administration of one dose, provides an analgesic effect within 2 hours, which analgesic effect continues for at least 24 hours after administration
    Type: Application
    Filed: April 22, 2005
    Publication date: January 4, 2007
    Inventors: Vincent Lenaerts, Laure Patricia Ouadji-Njiki, Johnatan Bacon, Rachid Ouzerourou, Sonia Gervais, Miloud Rahmouni, Damon Smith